Based on our forecasts, a long-term increase is expected, the "ZTS" stock price prognosis for 2025-12-30 is 338.377 USD. Get GlaxoSmithKline PLC (GSK:NYSE) real-time stock quotes, news and financial information from CNBC. View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business. At the same time, the Dow lost 0.35%, and the tech-heavy Nasdaq lost 0.28%. The GlaxoSmithKline deal included $20 million upfront as part of payments that could eventually total more than $650 million. Based on our forecasts, a long-term increase is expected, the "MRK" stock price prognosis for 2025-12-30 is 122.840 USD. Disclaimer. Your current $100 investment may be up to $113.4 in 2025. Factset: FactSet Research Systems Inc.2019. The 18 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 44.58, with a high estimate of 60.58 and a low estimate of 35.34. All Rights Reserved. GSK @GSK. ... MS and GSK. You contribute to define the Data Science scientific strategy, processes and objectives ensuring alignment with the Head of Personalized Vaccinology, DSDI and the GSK Vaccines R&D strategy. All rights reserved. This suggests that the stock has a possible downside of 2.9%. View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business. Press releases. and has now fallen 3 days in a row.During the day the stock fluctuated 7.93% from a day low at $168.25 to a day high of $181.60. GlaxoSmithKline Plc, Europe's biggest drugmaker, posted a forecast-beating rise in first-quarter earnings on Wednesday as cost savings helped to … Your current $100 investment may be up to $151.73 in 2026. Find the latest GLAXOSMITHKLINE PLC ORD 25P (GSK.L) stock quote, history, news and other vital information to help you with your stock trading and investing. Evaluation of Etsy stock downgraded after the last trading session. View the latest GSK stock quote and chart on MSN Money. See Baidu, Inc. (BIDU) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Your current $100 investment may be up to $205.41 in 2026. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-17 is 40.982 USD. All times are ET. GlaxoSmithKline plc (NYSE:GSK) posted its earnings results on Wednesday, October, 28th. about 14 hours ago GSK @GSK. Dec 23 / Zacks.com - Paid Partner Content. Stock Price Forecast The 18 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 45.43, with a high estimate of 60.58 and a low estimate of 33.51. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. As of Oct 09 +0.42 / +1.13%. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Get Our PREMIUM Forecast Now, from ONLY $6.69! Emma’s advice for anyone starting out in their … Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Find real-time SNY - Sanofi SA stock quotes, company profile, news and forecasts from CNN Business. Royal Dutch Shell plc () Stock Market info Recommendations: Buy or sell Royal Dutch Shell stock? Their forecasts range from $99.00 to $200.00. ... GSK GlaxoSmithKline +0.06 +0.18%: Data as of 7:13pm ET, 12/16/2020. Tweets from GSK. 28 equities research analysts have issued 12-month target prices for Skyworks Solutions' shares. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. With a 5-year investment, the revenue is expected to be around +105.41%. View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Watch breaking news videos, viral videos and original video clips on CNN.com. Find real-time PSX - Phillips 66 stock quotes, company profile, news and forecasts from CNN Business. Press releases for media. 17 December 2020 Vir Biotechnology and GSK announce start of NIH-sponsored ACTIV-3 trial evaluating VIR-7831 in hospitalised adults with COVID-19 ; 17 December 2020 FDA approves GSK’s BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US ; 11 December 2020 Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based … GlaxoSmithKline (GSK) closed at $35.35 in the latest trading session, marking a -1.91% move from the prior day. With a 5-year investment, the revenue is expected to be around +51.73%. Dive deeper with interactive charts and top stories of GLAXOSMITHKLINE PLC. Move your mouse over a quarter or year to see how estimates have changed over time. Delayed Data. © 2020 Cable News Network. 21 December 2020 ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe ; 18 December 2020 GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestones ET by Jaimy Lee CureVac starts Phase 3 clinical trial of … The pharmaceutical company reported $0.92 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.78 by $0.14. All rights reserved. Find real-time GLAXF - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. Get Our PREMIUM Forecast … 37.58. Emma Walmsley, Chief Executive Officer, GSK said: “GSK delivered continued good operating performance in Q2 despite the loss of exclusivity of Advair. GSK: GlaxoSmithKline plc Detailed Estimate. ... GlaxoSmithKline PLC (NYSE:GSK) Add to Watch List. Get the latest GlaxoSmithKline PLC (GSK) stock news and headlines to help you in your trading and investing decisions. The median estimate represents a +17.09% increase from the last price of 38.07. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over pastmonths for detail. Find the latest GlaxoSmithKline PLC (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing.